704 related articles for article (PubMed ID: 23371914)
1. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
Malhi GS; Tanious M; Das P; Coulston CM; Berk M
CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
[TBL] [Abstract][Full Text] [Related]
2. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
3. Chronic lithium treatment alters the excitatory/ inhibitory balance of synaptic networks and reduces mGluR5-PKC signalling in mouse cortical neurons.
Khayachi A; Ase A; Liao C; Kamesh A; Kuhlmann N; Schorova L; Chaumette B; Dion P; Alda M; Séguéla P; Rouleau G; Milnerwood A
J Psychiatry Neurosci; 2021 Jun; 46(3):E402-E414. PubMed ID: 34077150
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
Malhi GS; Outhred T
CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
[TBL] [Abstract][Full Text] [Related]
5. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
6. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
[TBL] [Abstract][Full Text] [Related]
7. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
8. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
9. Lithium - past, present, future.
Rybakowski JK
Int J Psychiatry Clin Pract; 2020 Nov; 24(4):330-340. PubMed ID: 33169645
[TBL] [Abstract][Full Text] [Related]
10. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
Li X; Ketter TA; Frye MA
J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447
[TBL] [Abstract][Full Text] [Related]
11. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.
Machado-Vieira R; Manji HK; Zarate CA
Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):92-109. PubMed ID: 19538689
[TBL] [Abstract][Full Text] [Related]
12. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
[TBL] [Abstract][Full Text] [Related]
13. The science and practice of lithium therapy.
Malhi GS; Tanious M; Das P; Berk M
Aust N Z J Psychiatry; 2012 Mar; 46(3):192-211. PubMed ID: 22391277
[TBL] [Abstract][Full Text] [Related]
14. The current understanding of lamotrigine as a mood stabilizer.
Hahn CG; Gyulai L; Baldassano CF; Lenox RH
J Clin Psychiatry; 2004 Jun; 65(6):791-804. PubMed ID: 15291656
[TBL] [Abstract][Full Text] [Related]
15. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.
Rapoport SI
ACS Chem Neurosci; 2014 Jun; 5(6):459-67. PubMed ID: 24786695
[TBL] [Abstract][Full Text] [Related]
16. Lithium treatment prevents stress-induced dendritic remodeling in the rodent amygdala.
Johnson SA; Wang JF; Sun X; McEwen BS; Chattarji S; Young LT
Neuroscience; 2009 Sep; 163(1):34-9. PubMed ID: 19501634
[TBL] [Abstract][Full Text] [Related]
17. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy changes after lithium treatment. Systematic review.
Szulc A; Wiedlocha M; Waszkiewicz N; Galińska-Skok B; Marcinowicz P; Gierus J; Mosiolek A
Psychiatry Res Neuroimaging; 2018 Mar; 273():1-8. PubMed ID: 29414126
[TBL] [Abstract][Full Text] [Related]
19. Potential neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment: preliminary results.
Bersani G; Quartini A; Zullo D; Iannitelli A
Hum Psychopharmacol; 2016 Jan; 31(1):19-28. PubMed ID: 26563456
[TBL] [Abstract][Full Text] [Related]
20. Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.
Nugent AC; Carlson PJ; Bain EE; Eckelman W; Herscovitch P; Manji H; Zarate CA; Drevets WC
J Psychopharmacol; 2013 Oct; 27(10):894-902. PubMed ID: 23926239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
